Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2023-04-14 AGM Information
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Notice of Annual General Meeting on 21 April 2023
AGM Information Classification · 99% confidence The document is explicitly titled 'INNKALLING TIL ORDINÆR GENERALFORSAMLING I ARCTIC BIOSCIENCE AS' (Notice of Ordinary General Meeting in Arctic Bioscience AS) and contains a detailed agenda for the meeting, including items like approval of annual accounts, board remuneration, and capital increases. The text is a formal notice convening a shareholder meeting. This directly corresponds to the definition of AGM-R (AGM Information), which covers presentations and materials shared during the Annual General Meeting. Although it mentions the Annual Accounts (item 4), the primary purpose and format of the document is the official notice/invitation to the AGM.
2023-04-14 English
Arctic Bioscience - Notice of Annual General Meeting on 21 April 2023
AGM Information Classification · 98% confidence The document explicitly states it is a "Notice of Annual General Meeting on 21 April 2023". It details the date, time, and format of the AGM and directs shareholders to an attached document for further information. Since this is an announcement about the meeting itself, rather than the full presentation materials (AGM-R) or the proxy solicitation materials (PSI), and it serves as a formal notice, it aligns best with the general category for meeting-related announcements or regulatory notices. Given the specific mention of the AGM notice, AGM-R is the most appropriate primary classification, as it pertains directly to the upcoming Annual General Meeting.
2023-04-14 English
Arctic Bioscience - Årsrapport 2022
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Arctic Bioscience for the year 2022. It contains a table of contents listing sections such as 'Board of Directors' Report', 'Income Statement', 'Balance Sheet', 'Notes to the Financial Statements', and 'Independent Auditors Report'. The document provides detailed financial figures for 2022 and 2021, business highlights, and strategic overviews, which aligns with the definition of an Annual Report (10-K). FY 2022
2023-03-29 English
Arctic Bioscience - Årsrapport 2022
Report Publication Announcement Classification · 99% confidence The document is titled "Arctic Bioscience - Årsrapport 2022" (Annual Report 2022) and explicitly states that the company has published its annual report for 2022, including the board's annual review and financial statements. However, the document itself is very short (2087 characters) and primarily serves to announce the publication of the report ("Rapporten er vedlagt børsmeldingen og er tilgjengelig på selskapets hjemmesider") and details an upcoming webcast/presentation of the results. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report should be classified as a Report Publication Announcement (RPA), rather than the full Annual Report (10-K). The content focuses on the announcement and the subsequent presentation details, not the full financial statements themselves.
2023-03-29 Norwegian
Arctic Bioscience - Annual report 2022
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Arctic Bioscience for the year 2022. It contains a table of contents listing sections such as 'Board of Directors' Report', 'Income Statement', 'Balance Sheet', 'Notes to the Financial Statements', and 'Independent Auditors Report'. The document provides detailed financial figures for 2022 and 2021, business highlights, and strategic overviews, which aligns with the definition of an Annual Report (10-K). FY 2022
2023-03-29 English
Arctic Bioscience - Annual report 2022
Report Publication Announcement Classification · 99% confidence The document explicitly states it is the "Arctic Bioscience - Annual report 2022" and mentions that the report "including the Board of Directors report and financial statements" has been released. However, the document itself is very short (2248 characters) and its primary function appears to be announcing the availability of the full report ("The report is attached to this stock notice and is available on the company's website") and simultaneously announcing a webcast to discuss the results. According to Rule #2 (The 'MENU VS MEAL' Rule), when a short document announces the publication of a full report, it should be classified as a Report Publication Announcement (RPA). Although the title suggests an Annual Report (10-K), the content structure strongly indicates an announcement about the release of that report, not the report itself.
2023-03-29 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.